Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PEMBROLIZUMAB Cause Thyroid function test abnormal? 87 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 87 reports of Thyroid function test abnormal have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.1% of all adverse event reports for PEMBROLIZUMAB.

87
Reports of Thyroid function test abnormal with PEMBROLIZUMAB
0.1%
of all PEMBROLIZUMAB reports
6
Deaths
27
Hospitalizations

How Dangerous Is Thyroid function test abnormal From PEMBROLIZUMAB?

Of the 87 reports, 6 (6.9%) resulted in death, 27 (31.0%) required hospitalization, and 2 (2.3%) were considered life-threatening.

Is Thyroid function test abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PEMBROLIZUMAB. However, 87 reports have been filed with the FAERS database.

What Other Side Effects Does PEMBROLIZUMAB Cause?

Malignant neoplasm progression (10,111) Death (4,744) Diarrhoea (4,251) Fatigue (3,833) Off label use (3,416) Product use in unapproved indication (3,191) Pyrexia (3,155) Rash (2,900) Nausea (2,670) Decreased appetite (2,486)

What Other Drugs Cause Thyroid function test abnormal?

LEVOTHYROXINE (619) NIVOLUMAB (110) ADALIMUMAB (98) ALEMTUZUMAB (94) LENVATINIB (90) CABOZANTINIB S-MALATE (82) SUNITINIB MALATE (75) AMIODARONE (66) LENALIDOMIDE (44) IPILIMUMAB (40)

Which PEMBROLIZUMAB Alternatives Have Lower Thyroid function test abnormal Risk?

PEMBROLIZUMAB vs PEMETREXED PEMBROLIZUMAB vs PEMIGATINIB PEMBROLIZUMAB vs PENICILLAMINE PEMBROLIZUMAB vs PENICILLIN PEMBROLIZUMAB vs PENICILLIN G

Related Pages

PEMBROLIZUMAB Full Profile All Thyroid function test abnormal Reports All Drugs Causing Thyroid function test abnormal PEMBROLIZUMAB Demographics